UnitedHealth stock: buy or sell?
August 19th, 2019
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx.
Should I buy UnitedHealth stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, UnitedHealth stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is UnitedHealth stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we gathered 15 ratings published for UNH stock in the last 30 days. The general sentiment of these ratings is bullish for UNH stock, with 12 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-4-17||Bank of America||n/a||Buy|
|2019-2-8||Credit Suisse Group||n/a||Buy|
UnitedHealth stock analysis
UnitedHealth ended today at $244.71 and declined a disappointing -0.40%.
Shares of UnitedHealth closed today at $244.71 and declined a disappointing -0.40%. Since July 11th when SMA50d and SMA100d crossed up, UNH price slipped $-2.77 per share (-1.12%).
UnitedHealth stayed steady a lame -0.40% this week. For 5 weeks in a row, price slid and lost a -4.49%. Early July UNH boosted an astounding 7.11% in just one week.
From a weekly outlook, UNH marked an uptrend of rising tops and rising bottoms. Since its last top by mid July at $268.69, price slid and bounced up back from $241.26. Breaking down under $241.26 would cancel the current uptrend and it might test lower supports. Note that $268.69 might act as a resistance line. Since price and 40-weeks moving average lines crossed down late July, UNH fell $-8.23 per share (-3.25%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support. Far behind is the all-time high UnitedHealth recorded early December and since then the price is -14.31% below that top.
UnitedHealth stock price history
UnitedHealth IPO was on October 17th, 1984 at $0.11 per share1. Since then, UNH stock surged a 222,363.60%, with an average of 6,540.10% per year. If you had invested right after UNH's IPO a $1,000 in UnitedHealth stock in 1984, it would worth $2,223,636.00 today.
1: Adjusted price after possible price splits or reverse-splits.
UnitedHealth stock historical price chart
UNH stock reached all-time highs on December with a price of $285.58.
UnitedHealth stock price target is $289.10Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' UNH stock price predictions in the hope that they will be met as they may be wrong and not met. We have 11 price targets for UnitedHealth stock published in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-7-19||Raymond James||Raises Target||$265.00||$300.00||13.2%|
|2019-7-12||Morgan Stanley||Raises Target||$285.00||$298.00||4.6%|
|2019-4-17||SunTrust Banks||Lowers Target||n/a||$300.00||-|
|2019-4-17||Raymond James||Lowers Target||$310.00||$265.00||-14.5%|
|2019-4-17||Morgan Stanley||Lowers Target||$315.00||$285.00||-9.5%|
|2019-4-17||Bank of America||Lowers Target||$320.00||$290.00||-9.4%|
|2019-2-8||Credit Suisse Group||Reiterates||n/a||$310.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on April, UnitedHealth escalated a more than good 10.11%. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, UnitedHealth annual revenues rocketed an exceptional 12.36% to $224,871.00 million dollars from $200,136.00 marked in 2017. Nevertheless, its profit margin (compared to revenues) stayed stable to 5.33%, that is $11,986.00 million. UnitedHealth fiscal year ends in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, UnitedHealth TTM sales up to March 2019 were $229,884.00 and income $12,617.00 million USD. When comparing this TTM figures with the last reported annuality, we can review UnitedHealth business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, stepped up a tiny 2.23%. Slightly worse, profit margin (net income/revenues) remained steady at 5.33%.
|2013||$122,500 M||-||$5,630 M4.6%||-|
|2014||$130,474 M||6.51%||$5,619 M4.3%||-0.20%|
|2015||$156,397 M||19.87%||$5,813 M3.7%||3.45%|
|2016||$184,012 M||17.66%||$7,017 M3.8%||20.71%|
|2017||$200,136 M||8.76%||$10,558 M5.3%||50.46%|
|2018||$224,871 M||12.36%||$11,986 M5.3%||13.53%|
|TTM||$229,884 M||2.23%||$12,617 M5.5%||5.26%|
Quarterly financial resultsUnitedHealth reported $59,903.00 million in sales for 2019-Q1, a 3.15% improvement compared to previous quarter. Reported quarter income marked $3,467.00 million with a profit margin of 5.79%. Profit margin remained constant a 0.55% compared to previous quarter when profit margin was 5.23%. When comparing sales to same quarter last year, UnitedHealth sales marked a wonderful gain and jumped a 9.13%. Looking back to recent quarterly results, UnitedHealth posted 7 positive quarters in a row.
|2017-Q2||$50,050 M||-||$2,280 M4.6%||-|
|2017-Q3||$50,320 M||0.54%||$2,490 M4.9%||9.21%|
|2017-Q4||$52,061 M||3.46%||$3,617 M6.9%||45.26%|
|2018-Q1||$54,890 M||5.43%||$2,836 M5.2%||-21.59%|
|2018-Q2||$55,731 M||1.53%||$2,922 M5.2%||3.03%|
|2018-Q3||$56,174 M||0.79%||$3,188 M5.7%||9.10%|
|2018-Q4||$58,076 M||3.39%||$3,040 M5.2%||-4.64%|
|2019-Q1||$59,903 M||3.15%||$3,467 M5.8%||14.05%|
UnitedHealth ownershipWhen you are planning to buy shares of a company, it's worth to review its ownership structure.
UnitedHealth shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.59% of all shares.
Bearish positions for UNH stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to UnitedHealth:
|Market cap||$232.6 B||$70.3 B||$8.2 B||$40.3 B|
|Total shares||950.3 M||257.2 M||173.6 M||135.0 M|
|Float shares||941.0 M||255.3 M||408.0 M||134.7 M|
|- Institutional holdings (%)||88.2%||91.4%||92.3%||96.4%|
|- Insider holdings (%)||0.6%||0.2%||2.4%||0.2%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%|
|Monday, August 19th, 2019|
|Day range||$244.09 - $248.49|
|Average true range||$5.78|
|50d mov avg||$249.71|
|100d mov avg||$243.74|
|200d mov avg||$250.23|
UnitedHealth performanceTo better understand UnitedHealth performance you must becnhmark its gains with other related stocks in same sector or industry. We compared UnitedHealth against Anthem, Centene and Humana in the following table:
UnitedHealth competitorsWe picked a few stocks to conform a list of UnitedHealth competitors to watch if you are interested in investing in UNH:
Latest UnitedHealth stock news
- Seeking AlphaWhy Investors Should Not Miss Out On The Entry Point In UnitedHealthJuly 31, 2019
- InvestorPlaceUnitedHealth Earnings: UNH Stock Dips Despite Q2 BeatJuly 18, 2019
- Investors.comDow Jones Futures: Netflix Dives On Subscriber Miss; IBM Falls As UnitedHealth, eBay Eye Buy PointsJuly 18, 2019
- Investors.comDow Jones Leads Stocks Higher; UnitedHealth, Amazon Stock RiseJuly 12, 2019
- Investors.comUnitedHealth, Goldman Sachs Help Dow Top The 27,000 LevelJuly 11, 2019